An accelerated pathway for targeted cancer therapies

Mark McClellan; Joshua Benner; Richard Schilsky; David Epstein; Ray Woosley; Stephen Friend; David Sidransky; Cindy Geoghegan; David Kessler

doi:10.1038/nrd3360

An accelerated pathway for targeted cancer therapies

Mark McClellan, Joshua Benner, Richard Schilsky, David Epstein, Ray Woosley, Stephen Friend, David Sidransky, Cindy Geoghegan, David Kessler

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.

Original language	English (US)
Pages (from-to)	79-80
Number of pages	2
Journal	Nature Reviews Drug Discovery
Volume	10
Issue number	2
DOIs	https://doi.org/10.1038/nrd3360
State	Published - Feb 1 2011

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Access to Document

10.1038/nrd3360

Fingerprint Dive into the research topics of 'An accelerated pathway for targeted cancer therapies'. Together they form a unique fingerprint.

Cite this

@article{5eae9572a9f14cfba7c07a93f7577dc2,

title = "An accelerated pathway for targeted cancer therapies",

abstract = "A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.",

author = "Mark McClellan and Joshua Benner and Richard Schilsky and David Epstein and Ray Woosley and Stephen Friend and David Sidransky and Cindy Geoghegan and David Kessler",

year = "2011",

month = feb,

day = "1",

doi = "10.1038/nrd3360",

language = "English (US)",

volume = "10",

pages = "79--80",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - An accelerated pathway for targeted cancer therapies

AU - McClellan, Mark

AU - Benner, Joshua

AU - Schilsky, Richard

AU - Epstein, David

AU - Woosley, Ray

AU - Friend, Stephen

AU - Sidransky, David

AU - Geoghegan, Cindy

AU - Kessler, David

PY - 2011/2/1

Y1 - 2011/2/1

N2 - A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.

AB - A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.

UR - http://www.scopus.com/inward/record.url?scp=79551609869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551609869&partnerID=8YFLogxK

U2 - 10.1038/nrd3360

DO - 10.1038/nrd3360

M3 - Review article

C2 - 21283090

AN - SCOPUS:79551609869

VL - 10

SP - 79

EP - 80

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 2

ER -